Live Quote · NASDAQHSKAHealthcare· Medical - Devices

Heska Corporation

$119.99 0.00%(+$0.00)
TickerSpark Score
67/100
Solid
70
Valuation
55
Profitability
25
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HSKA research report →

52-Week Range100% of range
Low
$57.83
Current
$119.99
High
$120.03
Company Overviewwww.heska.com

About the company

Heska Corporation provides specialized diagnostic and animal health products, predominantly for canine and feline veterinary care markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. Its product line includes a variety of veterinary chemistry analyzers: the Element DC, DCX, and DC5x series, along with the Element RC, RCX, and RC3X systems, all tailored for blood chemistry and electrolyte analysis. For hematological assessments, Heska offers the Element HT5 and scil Vet abc Plus analyzers, capable of measuring blood cell and platelet counts, as well as hemoglobin levels.

CEO
Kevin S. Wilson
IPO
1997
Employees
808
HQ
Loveland, CO, US

Price Chart

+31.18% · this period
$119.99$90.10$60.21Jun 10Dec 09Jun 12
Valuation
Market Cap
$1.31B
P/E
-67.41
P/S
5.09
P/B
2.94
EV/EBITDA
-61.88
Div Yield
0.00%
Profitability
Gross Margin
43.20%
Op Margin
-7.89%
Net Margin
-7.16%
ROE
-4.29%
ROIC
-3.12%
Growth & Income
Revenue
$257.31M · 1.41%
Net Income
$-18,424,000 · -14057.58%
EPS
$-1.78 · -13584.85%
Op Income
$-20,298,000
FCF YoY
-634.20%
Performance & Tape
52W High
$120.03
52W Low
$57.83
50D MA
$117.59
200D MA
$87.26
Beta
1.60
Avg Volume
336.67K

Get TickerSpark's AI analysis on HSKA

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 13, 23Davis Stephen Lsell500
Jun 13, 23Hasenmaier Joachim A.sell2,004
Jun 13, 23Eyl Steven M.other4,056
Jun 13, 23Eyl Steven M.other33,111
Feb 28, 22Eyl Steven M.other20,000
Jun 13, 23Eyl Steven M.sell1,146
Jun 13, 23Eyl Steven M.sell3,041
Jun 13, 23Eyl Steven M.sell1,918
Jun 13, 23Eyl Steven M.sell1,372
Jun 13, 23Eyl Steven M.sell7,691
Coverage · HSKA

Our HSKA coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on HSKA yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate HSKA report →
Internal Compare

Similar companies

Peers in the same neighborhood.